pharma

Cancer Drug Price Caps: Why Jefferies Chooses Smart Stocks

by Bradley Bryant 6 Min Reading

Cancer drug price caps are reshaping investment strategies. Discover why Jefferies favors Fortis, Apollo, and Manipal amidst scrutiny.

Share